'My Dear Heart' widens lead over rival show | ABS-CBN

ADVERTISEMENT

dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

Showbiz

'My Dear Heart' widens lead over rival show

'My Dear Heart' widens lead over rival show

ABS-CBN News

Clipboard

A post shared by Dreamscape PH (@dreamscapeph) on

The family drama "My Dear Heart" have opened up a more than 11-point ratings lead over its rival show, "Destined To Be Yours," according to data from Kantar Media, suggesting that the Coney Reyes-starrer about a kid who has a heart disease has Filipino viewers gripped.

Under Kantar Media's measurement, "My Dear Heart" enjoyed a national television rating of 30.5 percent for its Tuesday episode, beating the 18.9 percent of "Destined To Be Yours" topbilled by Maine Mendoza and Alden Richards.

Directed by Jerome Pobocan and Jojo Saguin, "My Dear Heart" also stars Ria Atayde, Nayomi "Heart" Ramos, Zanjoe Marudo and Bela Padilla. It began airing last January 23.

A post shared by Dreamscape PH (@dreamscapeph) on

A post shared by Dreamscape PH (@dreamscapeph) on

Meanwhile, "FPJ's Ang Probinsyano" kept its throne as the most watched show in the country, scoring 44.6 percent, or almost double that of the 24.5 percent of fantaserye "Encantadia."

ADVERTISEMENT

The Kapamilya network posted similar ratings battle victories in both noontime and afternoon timeslots, with "It's Showtime" (19 percent) getting the better of "Eat Bulaga" (13 percent). "The Better Half" and "The Greatest Love" recorded 15.8 percent and 15 percent, respectively, for Tuesday.

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.